Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy
Shigeo Ohba
, Takao Teranishi
, Kazuyasu Matsumura
,
Masanobu Kumon
,
Daijiro Kojima
, Eiji Fujiwara
, Kazutaka Nakao
, Kiyonori Kuwahara
,
Kazuhiro Murayama
, Eriel Sandika Pareira
,
Seiji Yamada
, Masahiro Joko
,
Shunsuke Nakae
,
Jun Muto
,
Yuya Nishiyama
,
Kazuhide Adachi
, Hikaru Sasaki
,
Masato Abe
, Mitsuhiro Hasegawa
,
Yuichi Hirose
Neurosurgery
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Temozolomide
100%
Radiotherapy
100%
Glioblastoma
100%
Karnofsky Performance Status
100%
IDH-wildtype
100%
Survival Time
13%
Median Survival
13%
Residual Tumor Size
13%
Improved Survival
6%
Patient Well-being
6%
Multivariate Analysis
6%
Univariate Analysis
6%
Tumor Resection
6%
Performance Status
6%
Concomitant Radiotherapy
6%
BCNU Wafer
6%
Medicine and Dentistry
Temozolomide
100%
Glioblastoma
100%
Karnofsky Performance Status
100%
Radiation Therapy
100%
Neoplasm
13%
Promoter Region
13%
Survival Time
13%
Quality of Life
6%
Multivariate Analysis
6%
Univariate Analysis
6%
Cancer Surgery
6%
Carmustine
6%